These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8360875

  • 21. Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds.
    Hudkins RL, Mailman RB, DeHaven-Hudkins DL.
    J Med Chem; 1994 Jun 24; 37(13):1964-70. PubMed ID: 8027978
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
    Bowen WD, Walker JM, de Costa BR, Wu R, Tolentino PJ, Finn D, Rothman RB, Rice KC.
    J Pharmacol Exp Ther; 1992 Jul 24; 262(1):32-40. PubMed ID: 1320690
    [Abstract] [Full Text] [Related]

  • 23. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
    Bonhaus DW, Loury DN, Jakeman LB, Hsu SA, To ZP, Leung E, Zeitung KD, Eglen RM, Wong EH.
    J Pharmacol Exp Ther; 1994 Oct 24; 271(1):484-93. PubMed ID: 7965749
    [Abstract] [Full Text] [Related]

  • 24. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ.
    Brain Res; 1996 Jul 01; 725(2):155-65. PubMed ID: 8836521
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis and biological evaluation of conformationally restricted σ(1) receptor ligands with 7,9-diazabicyclo[4.2.2]decane scaffold.
    Sunnam SK, Schepmann D, Rack E, Fröhlich R, Korpis K, Bednarski PJ, Wünsch B.
    Org Biomol Chem; 2010 Dec 21; 8(24):5525-40. PubMed ID: 20953473
    [Abstract] [Full Text] [Related]

  • 30. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies.
    Matsumoto RR, Potelleret FH, Mack A, Pouw B, Zhang Y, Bowen WD.
    Pharmacol Biochem Behav; 2004 Apr 21; 77(4):775-81. PubMed ID: 15099923
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist.
    Reddy NL, Hu LY, Cotter RE, Fischer JB, Wong WJ, McBurney RN, Weber E, Holmes DL, Wong ST, Prasad R.
    J Med Chem; 1994 Jan 21; 37(2):260-7. PubMed ID: 8295213
    [Abstract] [Full Text] [Related]

  • 33. Novel analogs of the sigma receptor ligand BD1008 attenuate cocaine-induced toxicity in mice.
    Matsumoto RR, Gilmore DL, Pouw B, Bowen WD, Williams W, Kausar A, Coop A.
    Eur J Pharmacol; 2004 May 10; 492(1):21-6. PubMed ID: 15145701
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Structure-affinity-relationship study of bicyclic sigma receptor ligands.
    Holl R, Geiger C, Nambo M, Itami K, Schepmann D, Wünsch B.
    Cent Nerv Syst Agents Med Chem; 2009 Sep 10; 9(3):220-9. PubMed ID: 20021356
    [Abstract] [Full Text] [Related]

  • 38. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
    Matsuno K, Nakazawa M, Okamoto K, Kawashima Y, Mita S.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):271-9. PubMed ID: 8813641
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Subchronic administration of N-[2-(3,4-dichlorophenyl) ethyl]-N-methyl-2-(dimethylamino) ethylamine (BD1047) alters sigma 1 receptor binding.
    Zambon AC, De Costa BR, Kanthasamy AG, Nguyen BQ, Matsumoto RR.
    Eur J Pharmacol; 1997 Apr 11; 324(1):39-47. PubMed ID: 9137911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.